Pre-Treatment T-Cell Receptors (TCR) Repertoire in Non-Small Cell Lung Cancer (NSCLC) Patients Treated With Single Agent Immunotherapy

被引:0
作者
Abed, A. [1 ]
Calapre, L. [2 ]
Bowyer, S. [3 ]
Millward, M. [4 ]
Gray, E. [2 ]
机构
[1] Linear Clin Res, Oncol, Nedlands, WA, Australia
[2] Edith Cowan Univ, Med Sci, Joondalup, WA, Australia
[3] Sir Charles Gairdner Hosp, Dept Med Oncol, Nedlands, WA, Australia
[4] Linear Clin Res, Nedlands, WA, Australia
关键词
T-CR repertoire; Non-small cell lung cancer; Immunotherapy;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
OA12.04
引用
收藏
页码:S870 / S870
页数:1
相关论文
共 50 条
  • [41] Khorana Score: A Potential New Biomarker for Real Life Non-Small Cell Lung Cancer (NSCLC) Patients Treated with Immunotherapy
    Bjornhart, B.
    Hansen, K.
    Jorgensen, T.
    Herrstedt, J.
    Schytte, T.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S980 - S981
  • [42] Immunotherapy in patients with non-small cell lung cancer with ECOG PS 2
    Mojsak, Damian
    Kuklinska, Beata
    Deczynski, Michal
    Mroz, Robert Marek
    [J]. WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2021, 25 (01): : 53 - 56
  • [43] Chemotherapy: A partnership with immunotherapy in non-small cell lung cancer
    Mendes, Ana Sofia
    Romao, Raquel
    Febra, Joana
    Azevedo, Sergio Xavier
    Fidalgo, Paula
    Araujo, Antonio
    [J]. THORACIC CANCER, 2023, 14 (05) : 437 - 441
  • [44] The State of the Art in Non-Small Cell Lung Cancer Immunotherapy
    Seetharamu, Nagashree
    [J]. SEMINARS IN THORACIC AND CARDIOVASCULAR SURGERY, 2014, 26 (01) : 26 - 35
  • [45] Current status of immunotherapy for non-small cell lung cancer
    Yang, Tao
    Xiong, Yilin
    Zeng, Yufei
    Wang, Yan
    Zeng, Jing
    Liu, Jie
    Xu, Shangfu
    Li, Li-Sheng
    [J]. FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [46] Combination of immunotherapy with targeted therapies in advanced non-small cell lung cancer (NSCLC)
    Moya-Horno, Irene
    Viteri, Santiago
    Karachaliou, Niki
    Rosell, Rafael
    [J]. THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2018, 10
  • [47] Computing the Impact of Immunotherapy on the Non-Small Cell Lung Cancer (NSCLC) Therapeutic Landscape
    Vaghani, V.
    Chandwani, S.
    Hirschmann, M.
    Dibaj, S.
    Landry, L. L.
    Roarty, E.
    Zhang, J.
    Rinsurnogkawong, W.
    Lewis, J.
    Lee, J.
    Roth, J. A. Jack A.
    Swisher, S.
    Heymach, J.
    Burke, T.
    Simon, G.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S901 - S902
  • [48] Genotyping Non-Small Cell Lung Cancer (NSCLC)
    Delia Campos-Parra, Alma
    Cruz-Rico, Graciela
    Arrieta, Oscar
    [J]. GACETA MEXICANA DE ONCOLOGIA, 2012, 11 (01): : 35 - 44
  • [49] Immunotherapy in Non-Small Cell Lung Cancer (NSCLC): Biomarkers Associated with Early Death
    Munoz Del Toro, Jacobo
    Olmedo, Eugenia
    Gomez, Ana
    Madariaga, Ainhoa
    Perez Templado, Josefa
    Gorospe, Luis
    Reguera, Pablo
    Soria, Ainara
    Gion, Maria
    Martinez, Olga
    Molina, Javier
    Villamayor, Maria
    Saavedra, Cristina
    Munoz, Gema
    Albarran, Victor
    Benito, Amparo
    Barquin, Arantzazu
    Cabanero, Alberto
    Alonso, Teresa
    Gajate, Pablo
    Grande, Enrique
    Garrido, Pilar
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1325 - S1326
  • [50] Targeted Therapy and Immunotherapy in the Treatment of Non-Small Cell Lung Cancer
    Shroff, Girish S.
    de Groot, Patricia M.
    Papadimitrakopoulou, Vassiliki A.
    Truong, Mylene T.
    Carter, Brett W.
    [J]. RADIOLOGIC CLINICS OF NORTH AMERICA, 2018, 56 (03) : 485 - +